| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.12B | 51.92B | 52.66B | 48.84B | 45.62B | 43.45B |
| Gross Profit | 9.20B | 9.54B | 9.65B | 9.13B | 7.75B | 8.04B |
| EBITDA | 2.83B | 2.75B | 3.18B | 3.54B | 2.65B | 3.40B |
| Net Income | 1.46B | 1.69B | 2.02B | 2.32B | 1.70B | 2.21B |
Balance Sheet | ||||||
| Total Assets | 17.58B | 18.10B | 18.11B | 16.07B | 15.08B | 14.41B |
| Cash, Cash Equivalents and Short-Term Investments | 2.22B | 1.81B | 1.73B | 1.32B | 1.42B | 1.17B |
| Total Debt | 5.20B | 4.62B | 4.49B | 4.30B | 5.81B | 5.56B |
| Total Liabilities | 8.28B | 7.84B | 7.94B | 7.81B | 8.60B | 8.94B |
| Stockholders Equity | 9.29B | 10.25B | 10.17B | 8.27B | 6.48B | 5.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.04B | 896.20M | 1.96B | 799.27M | 985.05M |
| Operating Cash Flow | 0.00 | 3.05B | 1.21B | 2.36B | 1.24B | 1.30B |
| Investing Cash Flow | 0.00 | -1.28B | -847.88M | -412.66M | -444.69M | -390.47M |
| Financing Cash Flow | 0.00 | -1.69B | 52.53M | -2.05B | -549.12M | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.84B | 12.04 | ― | 2.19% | 15.14% | 17.01% | |
80 Outperform | ¥143.68B | 12.49 | ― | 2.24% | 8.95% | 23.83% | |
79 Outperform | ¥33.26B | 10.78 | ― | 3.77% | 17.14% | 8.81% | |
74 Outperform | ¥35.95B | 5.26 | ― | 1.73% | 7.61% | 57.19% | |
66 Neutral | ¥19.98B | 14.00 | ― | 3.53% | -1.39% | -15.64% | |
65 Neutral | ¥225.72B | 14.06 | ― | 0.64% | 53.35% | 107.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |